Fridays vs Willow
Fridays costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Willow
Best for: seeing what it charges before you answer any medical questions
Visit Willow →If you are choosing between Fridays and Willow, the first difference is cost: Fridays is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Willow leads our six-part score, 6.6 to 5.5.
Fridays vs Willow price
Fridays is the cheaper way in: $249 a month against $299 a month at Willow. That is $50 less each month (17% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Fridays ($249 a month vs $299 a month); tirzepatide is cheaper at Fridays ($359 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Fridays prices compounded injections and brand-name pens, while Willow prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Fridays is the only one of the two with a brand-name price.
Where each one treats patients
Neither Fridays nor Willow publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Fridays
Willow
What each price covers
Both prices cover the clinician visit and the medication itself.
Fridays' price also covers coaching, which Willow does not claim.
Willow's price also covers shipping, which Fridays does not claim.
Fridays is silent on shipping and lab work.
Willow is silent on lab work and coaching.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Willow
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Willow scores 6.6 and Fridays 5.5 out of 10.
Willow is stronger on user experience (8.0 vs 3.0) and trust & safety (6.5 vs 4.0).
Value, effectiveness, accessibility and support are within half a point.
Fridays
5.5/10
Willow
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Willow has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Willow |
|---|---|---|
| Starting Price | ✓$249/mo | $299/mo |
| Features | 2 features | ✓3 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Willow
Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.
Read our full Willow review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Willow
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Willow
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Willow wins this one, 6.6 to 5.5, above all for seeing what it charges before you answer any medical questions. Fridays undercuts it by $50 a month, so if the monthly bill is what decides it, Fridays is the pick. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Willow if…
You want seeing what it charges before you answer any medical questions and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Fridays vs Willow: FAQ
Close alternatives to Fridays and Willow
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Willow vs Remedy Meds
- Willow vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.